Marsili A, Tang D, Harney JW, Singh P, Zavacki AM, Dentice M, Salvatore D, Larsen PR. Type II iodothyronine deiodinase provides intracellular 3,5,3=-triiodothyronine to normal and regenerating mouse skeletal muscle. Am J Physiol Endocrinol Metab 301: E818 -E824, 2011. First published July 19, 2011 doi:10.1152/ajpendo.00292.2011.-The FoxO3-dependent increase in type II deiodinase (D2), which converts the prohormone thyroxine (T 4) to 3,5,3=-triiodothyronine (T3), is required for normal mouse skeletal muscle differentiation and regeneration. This implies a requirement for an increase in D2-generated intracellular T3 under these conditions, which has not been directly demonstrated despite the presence of D2 activity in skeletal muscle. We directly show that D2-mediated T 4-to-T3 conversion increases during differentiation in C2C12 myoblast and primary cultures of mouse neonatal skeletal muscle precursor cells, and that blockade of D2 eliminates this. In adult mice given 125 I-T4 and 131 I-T3, the intracellular 125 I-T3/ 131 I-T3 ratio is significantly higher than in serum in both the D2-expressing cerebral cortex and the skeletal muscle of wild-type, but not D2KO, mice. In D1-expressing liver and kidney, the 125 I-T3/ 131 I-T3 ratio does not differ from that in serum. Hypothyroidism increases D2 activity, and in agreement with this, the difference in 125 I-T3/ 131 I-T3 ratio is increased further in hypothyroid wild-type mice but not altered in the D2KO. Notably, in wild-type but not in D2KO mice, the muscle production of 125 I-T3 is doubled after skeletal muscle injury. Thus, D2-mediated T4-to-T3 conversion generates significant intracellular T3 in normal mouse skeletal muscle, with the increased T3 required for muscle regeneration being provided by increased D2 synthesis, not by T3 from the circulation. type II deiodinase; skeletal muscle; regeneration; thyroid hormone action THYROXINE (T 4 ), THE PRINCIPLE SECRETORY PRODUCT of the thyroid gland, is a prohormone and must be monodeiodinated at the outer ring to form the active hormone 3,5,3=-triiodothyronine (T 3 ). Virtually all of the physiological effects of thyroid hormone are generated by the interaction of T 3 with its nuclear receptors. In humans, ϳ80% of the T 3 is derived from monodeiodination catalyzed by either the type I (D1) or the type II (D2) selenodeiodinase. The type I enzyme, highly expressed in liver, kidney, and the thyroid gland, is located in the plasma membrane with its active center in the cytosol. It is inhibited by the thiourea drug 6n-propylthiouracil (PTU) and provides much of the T 3 for the circulation (10). On the other hand, D2 is expressed in pituitary, central nervous system, thyroid, bone, brown adipose tissue and skeletal muscle (1, 29). It is insensitive to PTU and is located in the endoplasmic reticulum, with its active center in the cytosol. Programmed or induced changes in D2 expression permit tissue-specific changes in intracellular T 3 concentrations (1, 6, 10). Studies in rats have demonstrated that tissues expressing D2 ...